Sign in
A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study
Journal article   Peer reviewed

A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study

Geeta A LALWANI, Philip J ROSENFELD, Anne E FUNG, Sander R DUBOVY, Stephen MICHELS, William FEUER, Janet L DAVIS, Harry W FLYNN and Maria ESQUIABRO
American journal of ophthalmology, Vol.148(1), pp.43-58
2009
PMID: 19376495

Abstract

Biological and medical sciences Miscellaneous Medical sciences Ophthalmology Retinopathies

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.36 Ophthalmology
1.36.383 Diabetic Retinopathy
Web Of Science research areas
Ophthalmology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details